ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd (ENLV)

1,09
-0,03
(-2,68%)
Geschlossen 21 März 9:00PM
1,09
0,00
(0,00%)
Nach Börsenschluss: 10:59PM
Fortg. Diagramm

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
1,09
Gebot
1,07
Fragen
1,16
Volumen
159.811
1,05 Tagesbereich 1,13
0,8101 52-Wochen-Bereich 4,59
Marktkapitalisierung
Handelsende
1,12
Handelsbeginn
1,11
Letzte Trade
1
@
1.09
Letzter Handelszeitpunkt
Finanzvolumen
US$ 172.657
VWAP
1,0804
Durchschnittliches Volumen (3 Mio.)
141.522
Ausgegebene Aktien
20.880.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,78
Gewinn pro Aktie (EPS)
-1,39
Erlöse
-
Nettogewinn
-29,07M

Über Enlivex Therapeutics Ltd

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Ness Ziona, Center, Isr
Gegründet
-
Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was US$1,12. Over the last year, Enlivex Therapeutics shares have traded in a share price range of US$ 0,8101 to US$ 4,59.

Enlivex Therapeutics currently has 20.880.000 shares in issue. The market capitalisation of Enlivex Therapeutics is US$23,39 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.78.

ENLV Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.12-9.91735537191.211.291.071567071.15621658CS
40.043.809523809521.051.290.93872566991.09526877CS
12-0.14-11.38211382111.231.290.93871415221.11588338CS
26-0.46-29.67741935481.551.750.81011887851.22988632CS
52-2.95-73.01980198024.044.590.81011559241.46981608CS
156-4.32-79.85212569325.418.640.8101834292.37524543CS
260-2.8-71.97943444733.8929.40.81011728558.6750025CS

ENLV - Frequently Asked Questions (FAQ)

What is the current Enlivex Therapeutics share price?
The current share price of Enlivex Therapeutics is US$ 1,09
How many Enlivex Therapeutics shares are in issue?
Enlivex Therapeutics has 20.880.000 shares in issue
What is the market cap of Enlivex Therapeutics?
The market capitalisation of Enlivex Therapeutics is USD 23,39M
What is the 1 year trading range for Enlivex Therapeutics share price?
Enlivex Therapeutics has traded in the range of US$ 0,8101 to US$ 4,59 during the past year
What is the PE ratio of Enlivex Therapeutics?
The price to earnings ratio of Enlivex Therapeutics is -0,78
What is the reporting currency for Enlivex Therapeutics?
Enlivex Therapeutics reports financial results in USD
What is the latest annual profit for Enlivex Therapeutics?
The latest annual profit of Enlivex Therapeutics is USD -29,07M
What is the registered address of Enlivex Therapeutics?
The registered address for Enlivex Therapeutics is 14 EINSTEIN STREET, NESS ZIONA, CENTER, 7403618
What is the Enlivex Therapeutics website address?
The website address for Enlivex Therapeutics is www.enlivex.com
Which industry sector does Enlivex Therapeutics operate in?
Enlivex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PSTVPlus Therapeutics Inc
US$ 1,37
(168,10%)
357,75M
SAGSAG Holdings Ltd
US$ 1,15
(70,37%)
126,65M
OPTNOptiNose Inc
US$ 9,15
(52,50%)
2,17M
RGCRegencell Bioscience Holdings Ltd
US$ 44,06
(43,19%)
1,23M
NAOVNanoVibronix Inc
US$ 4,45
(36,50%)
1,06M
ELEVElevation Oncology Inc
US$ 0,2809
(-41,21%)
18,19M
BHILBenson Hill Inc
US$ 0,3969
(-38,50%)
1,47M
ADAPAdaptimmune Therapeutics PLC
US$ 0,28
(-37,65%)
14,05M
XHLDTEN Holdings Inc
US$ 0,99761
(-37,26%)
15,3M
LSELeishen Energy Holding Company Ltd
US$ 8,28
(-33,76%)
606,21k
PSTVPlus Therapeutics Inc
US$ 1,37
(168,10%)
357,75M
NVDANVIDIA Corporation
US$ 118,53
(0,86%)
247,95M
AGMHAGM Group Holdings Inc
US$ 0,077
(6,94%)
162,81M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,16
(0,25%)
147,13M
SAGSAG Holdings Ltd
US$ 1,15
(70,37%)
126,65M

ENLV Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen